Navigation Links
Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
Date:9/28/2010

AUSTIN, Texas, Sept. 28 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), today announced the initial dates and locations for the MAGPIX® road show, a multinational tour designed to showcase the recently-launched MAGPIX analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under an hour.  The innovative format of the tour lets users interact directly with the system and each other to enhance the sharing of a broad set of applications.

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)

"We are very excited to launch our MAGPIX road show series to allow researchers around the world to experience MAGPIX first hand," said Patrick J. Balthrop, president and chief executive officer of Luminex.  "This is an opportunity for scientists across many disciplines to see, in person, how MAGPIX easily allows them to harness the power of multiplexing and advance their research."

The MAGPIX road show events will feature a presentation from a MAGPIX user as well as an overview of the instrument and an explanatory animation of the technology.  EMD Millipore, the first distributor of the MAGPIX instrument worldwide, also will be on site for demonstrations and to answer questions at the U.S. events.

The following dates and locations have been scheduled for the MAGPIX road show in Europe:


September 13 – Luminex Europe Office, Oosterhout, The Netherlands

 

September 15 – Wageningen University, Wageningen, The Netherlands

 

September 28 – October 1 – Exhibiting at The Instrument, The Sounds of Technology Conference, Amsterdam, The Netherlands

 

October 5 - 7 – Exhibiting at the Biotechnica Conference, Hanover, Germany

 

October 20-21 – Luminex Planet xMAP Multiplexing Congress, Vienna, Austria

 
   

The following dates and locations have been scheduled for the MAGPIX road show in the U.S.:


November 2 – Longwood Galleria, Boston, MA

 

November 3 – Middlesex Lounge, Cambridge, MA

 

November 11 – The Bentley Reserve, San Francisco, CA

 

November 13 – University Club, San Diego, CA, in conjunction with the Society for Neuroscience Annual Meeting

 

December 13 – The Mask and Wig, Philadelphia, PA, in conjunction with the American Society for Cell Biology Annual Meeting

 
   

For more information on the entire MAGPIX road show, visit www.luminexcorp.com/magpix.

Based on Luminex's xMAP® Technology, the easy-to-use MAGPIX instrument is compact – comparable in size to a desktop computer – making it attractive to smaller and lower-volume laboratories and institutions with limited resources and bench space.  The instrument provides fast, accurate and easily reproducible results and can advance research across many disease states by bringing many types of multiplexing applications to scientists.  MAGPIX is easy to install out of the box and weighs less than 40 lbs., approximately 18 kg, making it simple and affordable to ship and deploy anywhere in the world.  The instrument was designed to meet the needs of scientists who have not been able to take advantage of the power of multiplexing because of resource or space limitations.

For more information on MAGPIX, call 512.219.8020, or visit www.luminexcorp.com/magpix.

About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP Technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP Technology can be obtained at www.luminexcorp.com.


Luminex Corporate Contact:

 

Harriss T. Currie, Vice President, Finance and Chief Financial Officer

 

512.219.8020

 

hcurrie@luminexcorp.com

 

   

Matthew Scalo

 

Sr. Director of Investor Relations

 

512.219.8020

 

mscalo@luminexcorp.com

 

   

Luminex Media Contact:

 

Nicole Cottrill

 

615.327.7999

 

ncottrill@seigenthaler.com

 
   
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
2. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
3. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
4. Luminex Corporation to Present at UBS Global Life Sciences Conference
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
7. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
8. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
11. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 2016 A key trend that ... emergence of new treatments. Cardax, a development stage life ... The therapy is expected to fulfil large unmet medical ... conducting studies to develop new treatments for osteoarthritis. One ... involved in osteoarthritis are being investigated, and early trials ...
(Date:5/26/2016)... WELLESLEY, Massachusetts , May 26, 2016 ... sequencing (NGS) has matured into an essential life science ... research and development applications. BCC Research reveals in its ... of a second growth phase, one powered by a ... applied fields.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ...
(Date:5/25/2016)... Deutschland und GERMANTOWN, Maryland , ... Zusammenarbeit mit Therawis bedient dringenden ...   QIAGEN N.V. (NASDAQ: ... bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics ... die Onkologie eingegangen zu sein. Ein erstes Projekt ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 2016 , ... Each year Standard Process Inc. ... this year’s Life University winner of a $2,500 scholarship from Standard ... Awards ceremony. , Outerbridge is approaching her last quarter at Life University in ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off ... 63 percent say grilling is their favorite way to cook a hot dog, far ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, ... members and suppliers for its inaugural Member Conference at the Paris Hotel in ... elevating the operational health of America’s healthcare providers. , The conference was highlighted ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... On Memorial ... and women who lost their lives in military battle for the country. The ... in 2015 to provide more programs that empower independence for disabled military veterans, as ...
(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
Breaking Medicine News(10 mins):